protein

SLC6A4

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SLC6A4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

320Connections
0Hypotheses
0Analyses
50Outgoing
50Incoming

Summary

SLC6A4 is a protein involved in neurodegeneration research. Key relationships include: associated with, transports, expressed in. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 158 entities in the SciDEX knowledge graph.

View on Wiki →

🔬 Protein Info
Gene SymbolSLC6A4 (SERT, 5HTT)
AliasesSERT, 5HTT, SAT2, hSERT
Chromosome17q11.2
Functionis a membrane protein that mediates the reuptake of serotonin (5-hydroxytryptamine, 5-HT) from the synaptic cleft back into presynaptic neurons.
Molecular Weight~70 kDa
Amino Acids630 aa
Exons14
PathwaysApoptosis, Epigenetic, Mapk, autophagy pathway
UniProt IDP31645
NCBI Gene ID6532
Ensembl IDENSG00000108576
Uniprot IDP31645
Protein Length630 amino acids
StepProcess
1Na+ binding to extracellular site
Associated DiseasesALS, Addiction, Alzheimer, Alzheimer'S Disease
InteractionsJUN, CASP3, ERK2, RHOT1, STING, SYN1
KG Connections320 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: SLC6A4 — AlphaFold P31645 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

SLC6A4 Gene — Serotonin Transporter

gene · 1892 words

SLC6A3 Gene

gene · 2629 words

Serotonin Signaling Pathway in Neurodegeneration

mechanism · 2600 words

Section 216: Advanced Pharmacogenomics for CBS/PSP

therapeutic · 2181 words

Section 160: Pharmacogenomics and Personalized Medicine in CBS/PSP

therapeutic · 2046 words

Section 216: Advanced Pharmacogenomics and Precision Therapeutics for CBS/PSP

therapeutic · 2034 words

Pathway Diagram

graph TD
    SLC6A4["SLC6A4 / SERT"] -->|"Reuptakes"| Serotonin["Serotonin / 5-HT"]
    Serotonin -->|"Modulates"| Mood["Mood Regulation"]
    SLC6A4 -->|"Polymorphisms affect"| Anxiety["Anxiety Disorders"]
    SLC6A4 -->|"Polymorphisms affect"| Depression["Major Depression"]
    SLC6A4 -->|"Associates with"| APOE["APOE Risk Factor"]
    SLC6A4 -->|"Interacts with"| CYP3A4["CYP3A4 Metabolism"]
    SLC6A4 -->|"Epigenetic via"| Methylation["DNA Methylation"]
    SLC6A4 -->|"Cross-reacts"| ADRB2["ADRB2 Adrenergic"]
    SLC6A4 -.Drug target.-> SSRIs["SSRIs / Antidepressants"]
    SLC6A4 -.Associated with.-> Dementia["Dementia Risk"]
    SLC6A4 -.Linked to.-> Alzheimer["Alzheimer's Disease"]

Outgoing (176)

TargetRelationTypeStr
Serotonin Reuptakemediatesprocess0.95
SUDassociated_withdisease0.72
Opioidassociated_withdisease0.65
Addictionassociated_withdisease0.65
Alzheimerassociated_withdisease0.65

Incoming (144)

SourceRelationTypeStr
MAOBassociated_withgene0.60
GABRA1associated_withgene0.60
CHATassociated_withgene0.60
CYP2D6associated_withgene0.60
APOEassociated_withgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found